Lopinavir/ritonavir and Arbidol not effective for mild-to-moderate COVID-19 in adults

An exploratory randomized, controlled study on the safety and efficacy of either lopinavir/ritonavir (LPV/r) or Arbidol–antivirals that are used in some countries against HIV-1 and to treat influenza , respectively–as treatments for COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, suggests that neither drug improves the clinical outcome of patients hospitalized with mild-to-moderate cases…

Details

Revealed: the secret life of godwits

To find out more about birds such as the black-tailed godwit, ecologists have been conducting long-term population studies using standardized information on reproductive behaviour–such as dates of egg-laying or hatching and levels of chick survival. New information gathered using geolocators on godwits in the Netherlands shows that traditional observation methods can lead to inaccurate data.…

Details

First official ATS practice guidelines for Sarcoidosis cover diagnosis and detection

April 20, 2020–New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis – an inflammatory disease that affects the lungs, lymph glands, and other organs. The American Thoracic Society has published an official clinical practice guideline in which a panel of experts strongly recommended…

Details